| NMES-BAT (n = 19) | TENS-BAT (n = 19) | Repeated measure ANOVA | |||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Pretreatment | Post-treatment | Follow-up | Pretreatment | Post-treatment | Follow-up |  | F | P | Partial η2 |
NRS-FRS at rest | 0.68 ± 1.46 | 0 ± 0* | 0 ± 0 | 0.42 ± 0.90 | 0.21 ± 0.54* | 0.42 ± 0.84 | Interaction | 2.61 | 0.11 | 0.07 |
group | 0.40 | 0.53 | 0.01 | |||||||
time | 4.65 | 0.03* | 0.11 | |||||||
NRS-FRS during shoulder AROM | 3.89 ± 3.00 | 0.95 ± 1.18* | 0.63 ± 0.83*# | 3.11 ± 2.16 | 1.63 ± 1.38* | 1.95 ± 1.84* | Interaction | 5.84 | 0.01# | 0.14 |
group | 0.69 | 0.41 | 0.02 | |||||||
time | 32.60 | <0.001* | 0.48 | |||||||
NRS-FRS during shoulder PROM | 5.79 ± 2.10 | 2.26 ± 2.05* | 2.11 ± 1.79*# | 5.16 ± 1.54 | 3.05 ± 1.27* | 3.84 ± 2.04*^ | Interaction | 11.83 | <0.001# | 0.25 |
group | 1.48 | 0.23 | 0.04 | |||||||
time | 79.27 | <0.001* | 0.69 | |||||||
BPI-SF question 3 worst pain | 5.95 ± 1.99 | 2.58 ± 2.17*# | 2.11 ± 1.76*# | 5.21 ± 2.18 | 3.95 ± 1.58* | 4.05 ± 2.04 | Interaction | 10.84 | <0.001# | 0.23 |
group | 2.61 | 0.12 | 0.07 | |||||||
time | 42.19 | <0.001* | 0.54 | |||||||
BPI-SF question 9 pain interference | 1.10 ± 1.20 | 0.32 ± 0.54* | 0.15 ± 0.30* | 0.93 ± 0.84 | 0.44 ± 0.56* | 0.42 ± 0.61* | Interaction | 1.64 | 0.21 | 0.04 |
group | 0.14 | 0.71 | 0.01 | |||||||
time | 20.62 | <0.001* | 0.36 |